Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd

JurisdictionAustralia Federal only
JudgeFrench CJ.,Hayne J,Crennan,Kiefel JJ.,Gageler J.
Judgment Date04 December 2013
Neutral Citation2013-1204 HCA A,[2013] HCA 50
Docket NumberS219/2012 & S1/2013
CourtHigh Court
Date04 December 2013
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
11 cases
  • InterPharma Pty Ltd v Hospira, Inc (No 5)
    • Australia
    • Federal Court
    • 20 June 2019
    ...Ltd v Sanofi-Aventis Australia Pty Ltd (No 2) [2012] FCAFC 102; 96 IPR 185; 204 FCR 494 Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50; 253 CLR 284 AstraZeneca AB v Apotex Pty Ltd [2014] FCAFC 99; 107 IPR 177; 226 FCR 324 AstraZeneca AB v Apotex Pty Ltd [2015] HCA 30; 257 C......
  • Minister for the Environment v Sharma
    • Australia
    • Full Federal Court (Australia)
    • 15 March 2022
    ...v Ellis [2010] HCA 55; 240 CLR 111 Anns v Merton London Borough Council [1978] AC 728 Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50; 253 CLR 284 Australian Conservation Foundation Inc v Minister for the Environment and Energy [2017] FCAFC 134; 251 FCR 359 Baker v Carr (196......
  • Australian Financial Services and Leasing Pty Ltd v Hills Industries Ltd
    • Australia
    • High Court
    • 7 May 2014
    ...Australian law: Competition and Consumer Act 2010 (Cth), Sched 2 — Australian Consumer Law, ss 18, 20, 21, 22.See also Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (2013) 88 ALJR 261 at 270 [17]–[18] per French CJ, 283–284 [71]–[72] per Hayne J; 304 ALR 1 at 9–10, 27; [2013] HCA 50 i......
  • Alphapharm Pty Ltd v H Lundbeck A/S
    • Australia
    • High Court
    • 5 November 2014
    ...Act. See, generally, Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (2013) 88 ALJR 261 at 302–303 [186]–[193]; 304 ALR 1 at 51–53; [2013] HCA 50. 79 IPAC Report at 5 80 ‘Government Response to the Report of the Industrial Property Advisory Committee, “Patents, Innovation and Competition ......
  • Request a trial to view additional results
16 firm's commentaries
  • Isolated genetic material: invention or land grab? The D'Arcy v Myriad Genetics case
    • Australia
    • Mondaq Australia
    • 12 January 2015
    ...in D'Arcy, above, n 9, at [158]. 28 Above, n 10,at [166]. 29 Patent number 686004 30 Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (2013) 304 ALR 1; 88 ALJR 261; [2013] HCA 50; BC201315312. 31 Above, n 10, at [206]. 32P Ng and W Liu "Raising the bar? The new patent law reforms and their......
  • High Court concludes that methods of medical treatment are patentable
    • Australia
    • Mondaq Australia
    • 14 December 2013
    ...4 December 2013, the High Court judgment in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd & Ors [2013] HCA 50 was delivered. This is the first occasion the High Court has considered whether methods of medical treatment of the human body are patentable inventions within the meaning o......
  • Clinical Trial Disclosures A Significant Risk To Patent Validity In Australia
    • Australia
    • Mondaq Australia
    • 9 August 2022
    ...Tyre & Rubber Co Ltd (1972) RPC 457 2 Also consistent with the High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd & Ors [2013] HCA 50 3 See, e.g., Regeneron Pharmaceuticals Inc v Genentech Inc [2012] EWHC 657 (Pat); Hospira UK Limited v Genentech Inc [2015] EWHC 1796 (Pat); [20......
  • News from Abroad -- Swiss-type Patent Claims in Australia
    • Australia
    • JD Supra Australia
    • 1 August 2019
    ...Lambert Company LLC v Generics (UK) Ltd t/a Mylan and another [2018] UKSC 56. [5] Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50. As are claims to therapeutics in ‘when used’ format, which have essentially the same scope as method claims, see Wellcome Foundation Ltd v Commi......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT